Rhythm Pharmaceuticals Stock Predictions

Data Just Made Palantir Worth $200B - Is This #1 Software Company Next?

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.

Sell

RYTM
Rhythm Pharmaceuticals

Last Price:

$56.69

Seasonality Move:

-19.12%

7 Day Trial

ALL ACCESS PASS

$ 7

Apple's Space Move Could Send This Pre-IPO Stock Soaring

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.

Rhythm Pharmaceuticals Stock Forecast

Over the next 52 weeks, Rhythm Pharmaceuticals has on average historically risen by 59.7% based on the past 7 years of stock performance.
Rhythm Pharmaceuticals has risen higher in 5 of those 7 years over the subsequent 52-week period, corresponding to a historical accuracy of 71.43%
Is Rhythm Pharmaceuticals Stock Undervalued?

The current Rhythm Pharmaceuticals [RYTM] share price is $56.69. The Score for RYTM is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
RYTM is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.

Will Rhythm Pharmaceuticals Stock Go Up Next Year?

Over the next 52 weeks, Rhythm Pharmaceuticals has on average historically risen by 59.7% based on the past 7 years of stock performance.

Rhythm Pharmaceuticals Stock Rating

Sell

Rhythm Pharmaceuticals (RYTM) is a Sell

Is Rhythm Pharmaceuticals overpriced?

Rhythm Pharmaceuticals has risen higher in 5 of those 7 years over the subsequent 52-week period, corresponding to a historical accuracy of 71.43%

Rhythm Pharmaceuticals Stock Price History

Is RYTM stock going to rise?

Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RYTM is experiencing selling pressure, which indicates risk of future bearish movement.

Stock Information

Stock Info

Exchange:

NASDAQ

Country:

United States

Industry:

Biotechnology

Sector:

Health Care

Type:

stock

Website:

rhythmtx.com

52-Week Data

52-Week High:

68.58

52-Week Low:

35.17

Prediction Charts

Market Cap:

3.5B

Price in USD:

56.69

Volume:

306.2K

Beta:

1.89

Technical Analysis

SMA50:

57.32

SMA100:

55.78

SMA200:

49.98

52-Wk Change:

13.27%

Stock Predictions

Is Rhythm Pharmaceuticals stock public?

Yes, Rhythm Pharmaceuticals is a publicly traded company.
What is the Rhythm Pharmaceuticals stock quote today?

The Rhythm Pharmaceuticals stock price is 56.69 USD today.
How to buy Rhythm Pharmaceuticals stock online?

You can buy Rhythm Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date	Opening	Closing	Minimum	Maximum
Jan-28	56.62	56.81	57.72	55.14
Jan-29	56.74	57.19	57.56	56.47
Jan-30	57.75	59.22	59.50	57.55
Jan-31	59.22	59.43	60.69	58.80
Feb-3	58.06	59.41	60.48	57.67
Feb-4	59.24	59.95	60.14	58.49
Feb-5	60.43	61.02	62.14	59.78
Feb-6	60.55	60.01	60.84	59.11
Feb-7	59.86	59.18	60.10	58.65
Feb-10	59.36	58.47	59.98	57.98
Feb-11	57.72	57.58	58.16	57.16
Feb-12	56.39	57.64	57.70	55.72
Feb-13	58.00	57.56	58.65	56.87
Feb-14	57.93	56.69	58.46	56.56

Rhythm Pharmaceuticals Earnings

Rhythm Pharmaceuticals Earnings Report: Per Share Rhythm Pharmaceuticals Earnings Q1 Q2 Q3 and Q4 last year and next year.

Rhythm Pharmaceuticals Forecast Revenue Growth

Rhythm Pharmaceuticals Stock Analysis: Historical quarterly revenues per share for Rhythm Pharmaceuticals and historical quarterly revenue growth:

Analysts estimate an earnings increase this quarter of $0.24 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.53 per share, and an increase next year of $1.80 per share.

* Rhythm Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.